China Metagenomics Market Size & Outlook, 2024-2030
The metagenomics market in China is expected to reach a projected revenue of US$ 244.2 million by 2030. A compound annual growth rate of 16.3% is expected of China metagenomics market from 2024 to 2030.
In terms of revenue, China accounted for 4.2% of the global metagenomics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China metagenomics market is projected to lead the regional market in terms of revenue in 2030.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 244.2 million by 2030.
China has one of the fastest growing and most advanced metagenomics markets. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.
Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies. Furthermore, NGS has proven to be a powerful tool during the COVID-19 pandemic. These factors have fueled the demand for NGS in China.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 61.47% in 2023.
Horizon Databook has segmented the China metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
China has one of the fastest growing and most advanced metagenomics markets. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.
Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies. Furthermore, NGS has proven to be a powerful tool during the COVID-19 pandemic. These factors have fueled the demand for NGS in China.
China Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
Others
Clinical Diagnostics
Drug Discovery
Biotechnology
Environmental
Food & nutrition
China Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
Whole Genome Sequencing
Shotgun Sequencing
Others
16S Sequencing
China Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
Sequencing & Data Analytics Services
Kits & Reagents
Software
China Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
Pre-sequencing
Sequencing
Data Analysis
Reasons to subscribe to Metagenomics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Metagenomics Market Outlook databook
Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.